ATE485255T1 - Verfahren zum kristallisieren von reduziertem coenzym q10 aus wässriger lösung - Google Patents

Verfahren zum kristallisieren von reduziertem coenzym q10 aus wässriger lösung

Info

Publication number
ATE485255T1
ATE485255T1 AT02746039T AT02746039T ATE485255T1 AT E485255 T1 ATE485255 T1 AT E485255T1 AT 02746039 T AT02746039 T AT 02746039T AT 02746039 T AT02746039 T AT 02746039T AT E485255 T1 ATE485255 T1 AT E485255T1
Authority
AT
Austria
Prior art keywords
reduced coenzyme
aqueous solution
crystallizing reduced
crystallizing
coenzyme
Prior art date
Application number
AT02746039T
Other languages
English (en)
Inventor
Takahiro Ueda
Shiro Kitamura
Yasuyoshi Ueda
Original Assignee
Kaneka Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kaneka Corp filed Critical Kaneka Corp
Application granted granted Critical
Publication of ATE485255T1 publication Critical patent/ATE485255T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00—Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/01—Preparation of ethers
    • C07C41/18—Preparation of ethers by reactions not forming ether-oxygen bonds
    • C07C41/26—Preparation of ethers by reactions not forming ether-oxygen bonds by introduction of hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00—Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/01—Preparation of ethers
    • C07C41/34—Separation; Purification; Stabilisation; Use of additives
    • C07C41/40—Separation; Purification; Stabilisation; Use of additives by change of physical state, e.g. by crystallisation
AT02746039T 2001-07-13 2002-07-15 Verfahren zum kristallisieren von reduziertem coenzym q10 aus wässriger lösung ATE485255T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2001214477 2001-07-13
JP2002114874 2002-04-17
PCT/JP2002/007146 WO2003006411A1 (en) 2001-07-13 2002-07-15 Method of crystallizing reduced coenzyme q10 from aqueous solution

Publications (1)

Publication Number Publication Date
ATE485255T1 true ATE485255T1 (de) 2010-11-15

Family

ID=26618742

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02746039T ATE485255T1 (de) 2001-07-13 2002-07-15 Verfahren zum kristallisieren von reduziertem coenzym q10 aus wässriger lösung

Country Status (10)

Country Link
US (1) US20040197886A1 (de)
EP (1) EP1408024B1 (de)
JP (1) JP4116540B2 (de)
KR (1) KR20040018456A (de)
CN (1) CN1266102C (de)
AT (1) ATE485255T1 (de)
AU (1) AU2002318846B2 (de)
CA (1) CA2453164A1 (de)
DE (1) DE60238056D1 (de)
WO (1) WO2003006411A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI329510B (en) 2001-10-10 2010-09-01 Kaneka Corp Method of stabilizing reduced coenzyme q10
TWI349039B (en) * 2001-12-27 2011-09-21 Kaneka Corp Processes for producing coenzyme q10
EP1583729B1 (de) * 2003-01-10 2018-06-06 Kaneka Corporation Verfahren zur aufreinigung von reduziertem coenzym q
US7358402B2 (en) 2003-09-10 2008-04-15 Kaneka Corporation Reduced coenzyme Q10 crystal with excellent stability and composition containing said reduced coenzyme Q10 crystal
US20060147542A1 (en) * 2004-12-24 2006-07-06 Tadao Ono Solid preparation containing reduced coenzyme Q10 and method for producing the same
US8067217B2 (en) * 2004-12-28 2011-11-29 Kaneka Corporation Method for preserving reduced coenzyme Q10
JPWO2007126086A1 (ja) * 2006-04-28 2009-09-10 株式会社カネカ 還元型補酵素ｑ１０の精製方法
US8568779B2 (en) * 2007-01-11 2013-10-29 Kaneka Corporation Method for producing coenzyme Q10 particle
KR101991143B1 (ko) * 2011-06-24 2019-06-19 가부시키가이샤 가네카 안정성이 우수한 환원형 보효소 q10 결정
JP2015131766A (ja) * 2012-04-27 2015-07-23 株式会社カネカ 還元型補酵素ｑ１０の製造方法
WO2020029017A1 (en) 2018-08-06 2020-02-13 Inner Mongolia Kingdomway Pharmaceutical Co., Ltd. Systems and methods for producing coenzyme q10
WO2020045571A1 (ja) * 2018-08-30 2020-03-05 株式会社カネカ 安定性に優れた還元型補酵素ｑ１０結晶の製造方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1883952A (en) * 1932-10-25 Sobation of new yobk
US2205096A (en) * 1937-03-19 1940-06-18 Union Oil Co Process for separating wax from wax-oil mixtures
US2560193A (en) * 1947-12-27 1951-07-10 Standard Oil Co Dehazing hydrocarbon oils
GB947643A (en) 1959-05-25 1964-01-22 Merck & Co Inc Substituted chroman compounds
US3066080A (en) * 1961-03-22 1962-11-27 Merck & Co Inc Fermentation production of coenzyme q-10
JPS5915894B2 (ja) * 1975-12-15 1984-04-12 ニツシンセイフン カブシキガイシヤ ホコウソｑノセイゾウホウホウ
US4220747A (en) * 1976-06-28 1980-09-02 Allied Chemical Corporation Crystalline diacetylene polymers
JPS5692238A (en) * 1979-12-26 1981-07-25 Ajinomoto Co Inc Separation and recovery of hydroquinone derivative
JP3889481B2 (ja) * 1996-08-16 2007-03-07 株式会社カネカ 医薬組成物
JPH1085502A (ja) * 1996-09-19 1998-04-07 Konica Corp 晶析方法
AT408226B (de) * 1999-05-05 2001-09-25 Biochemie Gmbh Kristalliner 7-(2-(2-formylaminothiazol-4-yl)-2
US6740338B1 (en) * 2000-01-20 2004-05-25 Raj K. Chopra Reduced form of Cenzyme Q in high bioavailability stable oral dosage form
AU2001247331A1 (en) * 2000-03-10 2001-09-24 Pharmacia Corporation Combination therapy for the prophylaxis and treatment of hyperlipidemic conditions and disorders

Also Published As

Publication number Publication date
JP4116540B2 (ja) 2008-07-09
EP1408024A4 (de) 2006-02-01
US20040197886A1 (en) 2004-10-07
AU2002318846A2 (en) 2003-01-29
CA2453164A1 (en) 2003-01-23
WO2003006411A1 (en) 2003-01-23
EP1408024B1 (de) 2010-10-20
EP1408024A1 (de) 2004-04-14
KR20040018456A (ko) 2004-03-03
CN1266102C (zh) 2006-07-26
JPWO2003006411A1 (ja) 2004-11-04
CN1551862A (zh) 2004-12-01
DE60238056D1 (de) 2010-12-02
AU2002318846B2 (en) 2008-06-12

Similar Documents

Publication Publication Date Title
DE60102016D1 (de) Verfahren zur behandlung von beweggungsstörungen
DE50115863D1 (de) Verfahren zur regelung der fahrstabilität
ATE485255T1 (de) Verfahren zum kristallisieren von reduziertem coenzym q10 aus wässriger lösung
DE10197144T1 (de) Verfahren zur Herstellung von Nitrilverbindungen aus ethylenisch ungesättigten Verbindungen
DE60117033D1 (de) Verfahren zur hydrocyanierung von äthylenisch ungesättigten organischen verbindungen
DE602004024402D1 (de) Verfahren zur herstellung von tetrazolderivaten au
DE60330746D1 (de) Integriertes Verfahren zur selektiven Oxydation von organischen Verbindungen
DK1328499T3 (da) Fremgangsmåde til fremstilling af carboxylsyresalte
DE60235331D1 (de) Verfahren zur Herstellung von quartären Ammoniumsalzen
AU2001293034A1 (en) Process for removing sulfate from an aqueous salt solution
DE60238398D1 (de) Verfahren zur inhibierung von kalziumsalzablagerungen
DE60215867D1 (de) Verfahren zur herstellung von penamderivaten aus cephamderivaten
DE60239286D1 (de) Verfahren zur herstellung von trans-1,4-cyclohexandicarbonsäure
DE60336822D1 (de) Verfahren zur herstellung von kristallinem 1,2-polybutadien
ATE424892T1 (de) Verfahren zur herstellung von derivaten des 4a,5, 9,10,11,12-hexahydrobenzofuro ä3a,3,2üä 2 ü- benzazepins
DE60301019D1 (de) Verfahren zur Stabilierung sauerer Milchgetränke
ATE275149T1 (de) Verfahren zur herstellung von taxanderivaten
ATE413867T1 (de) Methode zur behandlung von bewegungsstörungen mit barbitursäure derivaten.
ATE374757T1 (de) Verfahren zur herstellung von (1,4,5)- oxadiazepinderivaten
ATE274599T1 (de) Verfahren zur enzymatischen racematspaltung von aminomethyl-aryl-cyclohexanol-derivaten
DE69905772T2 (de) Verfahren zur rückgewinnung von 3,4-epoxy-1-buten
ATE375730T1 (de) Verfahren zur kontrolle von haarballen
ITRM20010309A1 (it) Procedimento per la produzione di composti perfluoro-organici mediante florurazione elettrochimica.
DK1682476T3 (da) Fremgangsmåde til fremstilling af myresyreformiater
ATE375962T1 (de) Wässrige lösung aus einer bismutverbindung und einer polyhydroxyverbindung sowie verfahren zu ihrer herstellung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties